ホーム>>Signaling Pathways>> Neuroscience>> Neuroendocrinology>>Neuromedin S (rat) (trifluoroacetate salt)

Neuromedin S (rat) (trifluoroacetate salt) (Synonyms: NMS)

カタログ番号GC44378

ニューロメジンSは、ニューロメジンU(NMU)受容体の神経ペプチドアゴニストであり、NMU1およびNMU2を過剰発現するCHO細胞内のカルシウム濃度を増加させます(EC50はそれぞれ65および91 pMです)。

Products are for research use only. Not for human use. We do not sell to patients.

Neuromedin S (rat) (trifluoroacetate salt) 化学構造

サイズ 価格 在庫数 個数
500μg
$552.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Neuromedin S is a neuropeptide agonist of the neuromedin U (NMU) receptors that increases calcium concentrations in CHO cells overexpressing NMU1 and NMU2 (EC50s = 65 and 91 pM, respectively). Neuromedin S (1 nmol, i.c.v.) induces phase shifts in the circadian rhythm of locomotor activity in rats without altering the circadian period length. It also suppresses food and water intake in a dose-dependent manner when administered to rats during the dark period at doses ranging from 0.1 to 5 nmol. Co-administration of neuromedin S (1 nmol, i.c.v.) inhibits the ability of neuropeptide Y , ghrelin , and agouti-related protein (ARP) to stimulate food intake in rats by greater than 50%. Neuromedin S (0.2 nmol, i.c.v.) increases vasopressin levels in rat plasma within five minutes to levels five times greater than a saline control and decreases urinary volume by 25% during the dark period.

レビュー

Review for Neuromedin S (rat) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Neuromedin S (rat) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.